Stocksigma LogoStocksigma Logo

Gland Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

■ Revenue: 18,336 (+23.3% YoY | +1.9% QoQ) ■ EBITDA: 4,840 (+54.2% YoY | -1.1% QoQ) ■ EBITDA Margin (%): 26.4 (+529 bps YoY | -78 bps QoQ) ■ PAT: 2,908

Gland Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million)

Gland Pharma Ltd · Outcome · 06 Nov 2026, 10:03 pm

Gland Pharma Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Million) ■ Revenue: 18,336 (+23.3% YoY | +1.9% QoQ) ■ EBITDA: 4,840 (+54.2% YoY | -1.1% QoQ) ■ EBITDA Margin (%): 26.4 (+529 bps YoY | -78 bps QoQ) ■ PAT: 2,908 (+58.3% YoY | -8.3% QoQ) ■ EPS (INR): 17.6 (+58.0% YoY | -8.3% QoQ)

Original exchange filing (PDF)

More announcements from Gland Pharma Ltd

All Gland Pharma Ltd announcements